the corresponding tocotrienols ( ␣ TE,  TE, ␥ TE, and ␦ TE) ( Fig. 1 ). Among the members of the vitamin E family, ␣ T is the predominant form in tissues and is preferentially bound to a tocopherol transport protein that prevents ␣ T from being extensively metabolized ( 1 ). In contrast, other vitamin E forms are largely metabolized in the liver via -hydroxylation and oxidation to generate 13 ′ -hydroxychromanol (13 ′ -OH) and 13 ′ -carboxychromanol (13 ′ -COOH), the latter of which is subsequently metabolized via  -oxidation to various shorter-chain carboxychromanols including the terminal metabolite observed in urine, 3 ′ -COOH [or 2-(  -carboxyethyl)-6-hydroxychroman (CEHC)] ( Fig. 2 ) ( 1-3 ). In parallel with  -oxidation, long-chain carboxychromanols and CEHCs appear to be conjugated via sulfation to form conjugated carboxychromanols ( Fig. 2 ) ( 4,5 ). The terminal metabolite CEHCs and their conjugated forms are found in the urine ( 6-11 ). On the other hand, unconjugated short-, mid-, and long-chain carboxychromanols have recently been detected in feces after supplementation of ␥ T or ␦ T ( 12-14 ).Although research on vitamin E has predominantly focused on tocopherols and tocotrienols, their metabolites have been shown to have biological activities that are stronger than or differ from the unmetabolized vitamins. For instance, ␥ -CEHC has been reported to have natriuratic activity in vitro and in animals ( 15 ). Recent studies including ours have demonstrated that long-chain carboxychromanols appear to have unique anti-infl ammatory effects by inhibition of cyclooxygenases and 5-lipoxygenase and induced apoptosis in cancer cells (16)(17)(18). For these activities, long-chain carboxychromanols are much stronger than tocopherols or shorter-chain carboxychromanols. Despite these interesting fi ndings of vitamin E metabolites, Abstract Tocopherols and tocotrienols are metabolized via hydroxylation and oxidation of their hydrophobic side chain to generate 13 ′ -hydroxychromanols (13 ′ -OHs) and various carboxychromanols, which can be further metabolized by conjugation including sulfation. Recent studies indicate that long-chain carboxychromanols, especially 13 ′ -carboxychromanol (13 ′ -COOH), appear to be more bioactive than tocopherols in anti-infl ammatory and anticancer actions. To understand the potential contribution of metabolites to vitamin E-mediated effects, an accurate assay is needed to evaluate bioavailability of these metabolites. Here we describe an LC/MS/MS assay for quantifying vitamin E metabolites using negative polarity ESI. This assay includes a reliable sample extraction procedure with effi cacy of Ն 89% and interday/intraday variation of 3-11% for major metabolites. To ensure accurate quantifi cation, short-chain, long-chain, and sulfated carboxychromanols are included as external/ internal standards. Using this assay, we observed that sulfated carboxychromanols are the primary metabolites in the plasma of rodents fed with ␥ -tocopherol or ␦ -tocopherol. Although plasma levels of 13...